United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68382-205_e85a763f-472b-492b-bf25-a30251b9b50b
Product NDC
68382-205
Form
TABLET, FILM COATED
Composition / generic term
Gabapentin
Labeler
Zydus Pharmaceuticals USA Inc.
Marketing category
ANDA
Marketing start / end (source format)
20121016
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE (68382-205-01) · 68382-205-01
  • 500 TABLET, FILM COATED in 1 BOTTLE (68382-205-05) · 68382-205-05
  • 1000 TABLET, FILM COATED in 1 BOTTLE (68382-205-10) · 68382-205-10
  • 100 BLISTER PACK in 1 CARTON (68382-205-77) / 1 TABLET, FILM COATED in 1 BLISTER PACK (68382-205-30) · 68382-205-77

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →